Bull
$4.36
Scenario price
$7.290
+0.238 (+3.26%)At close
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
SOPHiA Genetics is currently a hold due to its recent performance and mixed signals. The stock is priced at $7.41, with a 1-year change of +83.42%, indicating strong growth over the past year. However, the RSI is at 34.9, suggesting it is in oversold territory, which may indicate a potential rebound. The company's gross margin is relatively high at 64.61%, but it continues to report significant losses, with a net income loss of $22.4 million in Q2 2026. The main risk is the negative earnings surprise of -73.33% in the last quarter, which could affect investor confidence.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

SOPHiA and Myriad Collaborate to Advance Prostate Cancer Genomic Technology

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript

Biotech Stocks Reach 52-Week Highs Driven by Key Catalysts

Sophia Genetics to Develop Cancer Diagnostic Tests

SOPHiA Genetics Q2 Earnings Beat Expectations with Revenue Growth
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide. It operates in the Healthcare sector.
SOPHiA Genetics is currently a hold due to its recent performance and mixed signals. The stock is priced at $7.41, with a 1-year change of +83.42%, indicating strong growth over the past year. However, the RSI is at 34.9, suggesting it is in oversold territory, which may indicate a potential rebound. The company's gross margin is relatively high at 64.61%, but it continues to report significant losses, with a net income loss of $22.4 million in Q2 2026. The main risk is the negative earnings surprise of -73.33% in the last quarter, which could affect investor confidence.

SOPH at $0.0044 — would you take the bet? First, the surface view: down 96%, retail calls it a "dead coin." TGE in May 2025, ATH around 0.088–0.11, now at 0.0044, a drop of over 95%. On-chain daily activity is very low, fee revenue is close to zero, and the community is quiet. The chart says: long-term downtrend, all moving averages bearish, RSI 40–50. Is this thing heading to zero? First point: the team shut down its own chain, but what looks like a rug pull is actually a self-rescue. On June 25, 2026, Sophon announced it was shutting down the Validium L2 on zkSync and pivoting to a consumer product studio on Base (Soph+). The reason is straightforward: value is at the application layer, not in running another chain. Annual operating costs cut by $3–3.4 million, with resources going entirely into product. Before: burning money to run a chain nobody used, pure loss Now: building products, using revenue to buy back and burn SOPH 46.5 million tokens already burned on June 28, about 0.5% of total supply Second point: the token model changed, but you may have missed it. SOPH used to rely on gas/staking narratives; now it's product revenue buyback and permanent burn. It depends on real revenue from products like Pyre — card swap fees, vault performance fees, stablecoin reserve yield. Before it was promises; now it really has to make money from products. If it can't, the token keeps falling. Pyre is positioned for "entertainment finance" everyday payments, with gamified mechanics; some materials say it is already live. Third point: 170 million tokens unlock on September 27–29, a very delicate timing. That's about 1.7% of total supply, with an impact on circulating market cap in the roughly 3% range. At the same time, the final batch of Guardian/node rewards settles and migrates to Ethereum. Low market cap plus high turnover (24h volume often several times market cap) means unlocks and sentiment shifts get priced in quickly. Upside resistance: 0.0047–0.00485 → 0.0052–0.0055 → 0.006 Downside support: 0.0042–0.0043 → 0.0038–0.0040 → 0.00327 (previous low) Bulls versus bears, you decide On one side: The team is cutting costs, burning tokens, and firmly committed to the pivot If Pyre works, the buyback-and-burn flywheel starts Down 96%, FDV only $44 million, market cap $8.8–18 million, deeply undervalued Long-term downtrend shows signs of a breakout; key level to watch is 0.0048–0.0049 On the other side: 170 million tokens unlock on September 27–29, selling pressure ahead Macro is tight, FOMC is near, rate hike expectations are rising Pyre's real user and revenue data is not transparent Low liquidity depth; the chart often spikes in a day and gives it all back Strategy Short-term traders: If it cannot break above 0.0047–0.00485 on volume, consider a light short at 0.00455–0.00470, stop above 0.00495, target 0.0042, second target 0.0039–0.004. Those playing a rebound: Only consider a light long if 0.0042–0.0043 stabilizes with a high-volume long lower wick or bullish divergence, stop below 0.00405, target 0.0047–0.00485. Long-term believers: Wait until the unlock is absorbed and Pyre data is verified. Below 0.0035, a very small position could be used to bet on the buyback narrative, but don't treat it as a "cheap value coin" — this is a high-risk thematic token, not a steady asset. This SOPH pivot is a snapshot of small-cap coins in 2026 — 99% of people think "down 96% means it's going to zero," but the team cut the chain, pivoted, burned tokens, built products, and climbed out of the ruins. The day it holds 0.0049, you'll realize: It wasn't that SOPH couldn't make it — it's that you only know how to sell after a 96% drop. At 0.0044, would you take the bet? $BTC $ETH $SOPH
Show more
$SOPH $MET $GAIB After a few investments that didn’t turn out as expected, I realized I needed to change how I evaluated opportunities. I stopped focusing on whatever was trending and started paying more attention to market conditions, timing, and the reasoning behind an investment. That’s what led me to CY WATSON. His perspective helped me approach crypto investing in a more informed way. I’d recommend checking out his insights if you’re new to the space and trying to develop your own investment strategy.
Show more
$SOPH Surely no one else is thinking of chasing longs here, right?? Brother Gang has been posting about shorting since the night before last — anyone still not caught up? Things played out pretty much as Brother Gang expected. With a low-market-cap coin like this, the project team only needs to hype up market attention to keep pushing the price higher. Once the pump is done, those still chasing longs will only end up stuck and harvested by the team!! On-chain funds are still continuously flowing out. The current sideways movement is just a tactic to lure retail in. If you're trading short-term, make sure to set take-profit and stop-loss levels to avoid excessive losses.
Show more
This Bonk Guy is back at it again, claiming $USELESS is the next PEPE before its 2023 surge, and even putting his own reputation on the line. It just got listed on a Korean exchange. Yesterday, I noticed the trend wasn't looking right, so I cut my losses and exited. Something feels off—it just won't drop. Glad I left yesterday; otherwise, today's price would have been rough for my short position. He says USELESS's current chart mirrors PEPE right before its massive 2023 rally—same volume structure, growing open interest, early relative strength. Almost a carbon copy. What did PEPE do in 2023? It went up 370,000x in 21 days. From near zero to an $1.8B market cap. But if this coin did 370,000x, what would that be? Over ten grand? This Bonk Guy is exaggerating again. His exact words: "Crypto has a phenomenon—the higher the price, the more attractive the asset seems." For me, I only buy things that offer real value for the price. Everything else, I short. I don't chase highs. $PONS also got pumped by his calls. I took a small short, grabbed some profit, and moved on. There's definitely money moving in USELESS. But with meme coins, when they rise, they're PEPE; when they fall, they go to zero. Wish it would be more like $SOPH's team—straightforward. It dropped all the way from 0.012, they took their profits and left. This USELESS team is just getting greedy.
Show more
$SOPH opportunity hides within fear. Yesterday morning's intense posts about surges came with sharp pullbacks—rallies often serve distribution purposes. For those taking short positions, managing position size is key while waiting patiently. Many traders exit too early simply due to poor position management or fear. In my view, holding a short requires tolerance for volatility; if you cannot withstand even a 100x move in altcoins, shorting may not be suitable. Yesterday I mentioned a stop-loss at 0.125, and the wick hit exactly 0.1248—a precise exit. ⚠️ Always control your position size when shorting—no one gets rich overnight. Wishing everyone success!
Show moreThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.